• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Case of Parkinson's Disease with No Lewy Body Pathology due to a Homozygous Exon Deletion in .一例因纯合外显子缺失导致无路易体病理改变的帕金森病病例
Case Rep Neurol Med. 2018 Jun 28;2018:6838965. doi: 10.1155/2018/6838965. eCollection 2018.
2
Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.路易体帕金森病伴杂合型帕金森蛋白剂量突变
Mov Disord. 2014 Apr;29(4):566-8. doi: 10.1002/mds.25792. Epub 2013 Dec 27.
3
Lewy bodies and parkinsonism in families with parkin mutations.携带帕金基因突变的家族中的路易小体与帕金森症
Ann Neurol. 2001 Sep;50(3):293-300. doi: 10.1002/ana.1132.
4
PINK1-linked parkinsonism is associated with Lewy body pathology.PINK1 相关性帕金森病与路易体病理相关。
Brain. 2010 Apr;133(Pt 4):1128-42. doi: 10.1093/brain/awq051. Epub 2010 Mar 30.
5
Neuropathological findings in PINK1-associated Parkinson's disease.与PINK1相关的帕金森病的神经病理学发现。
Parkinsonism Relat Disord. 2020 Sep;78:105-108. doi: 10.1016/j.parkreldis.2020.07.023. Epub 2020 Aug 9.
6
An autopsy case of PARK2 due to a homozygous exon 2 deletion of parkin and associated with α-synucleinopathy.一例因parkin基因外显子2纯合缺失导致的PARK2尸检病例,并与α-突触核蛋白病相关。
Neuropathology. 2021 Aug;41(4):293-300. doi: 10.1111/neup.12735. Epub 2021 Jun 13.
7
Lewy body pathology in a patient with a homozygous parkin deletion.路易体病理改变见于一名纯合子 parkin 缺失患者。
Mov Disord. 2013 Mar;28(3):388-91. doi: 10.1002/mds.25346. Epub 2013 Feb 11.
8
An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene.一例常染色体隐性青少年帕金森病尸检病例,其帕金基因第4外显子存在纯合缺失。
Mov Disord. 2000 Sep;15(5):884-8. doi: 10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8.
9
Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.对适合进行深部脑刺激的帕金森病患者进行丘脑底核谷氨酸脱羧酶基因转移。
Hum Gene Ther. 2001 Aug 10;12(12):1589-91.
10
Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.帕金森病黑质致密部神经元中的神经丝信使核糖核酸减少。
J Comp Neurol. 1993 Mar 15;329(3):328-36. doi: 10.1002/cne.903290304.

引用本文的文献

1
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease.需要一种个性化且全面的方法来抑制或补充帕金森病中的α-突触核蛋白(SNCA)。
NPJ Parkinsons Dis. 2025 Mar 4;11(1):42. doi: 10.1038/s41531-025-00887-3.
2
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson's Disease: Exploring Nanoparticle-based Gene Therapies.解析酪氨酸和酪氨酸羟化酶在帕金森病中的作用:探索基于纳米颗粒的基因疗法。
CNS Neurol Disord Drug Targets. 2025;24(5):325-339. doi: 10.2174/0118715273336139241211071748.
3
Imaging spatial transcriptomics reveals molecular patterns of vulnerability to pathology in a transgenic α-synucleinopathy model.成像空间转录组学揭示了转基因α-突触核蛋白病模型中病理易感性的分子模式。
bioRxiv. 2024 Dec 14:2024.07.31.606032. doi: 10.1101/2024.07.31.606032.
4
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.中脑多巴胺能神经元亚分型的研究现状
Biology (Basel). 2024 Sep 3;13(9):690. doi: 10.3390/biology13090690.
5
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers.靶向细胞毒性α-突触核蛋白寡聚体的单克隆抗体的分子特性及诊断潜力
NPJ Parkinsons Dis. 2024 Jul 29;10(1):139. doi: 10.1038/s41531-024-00747-6.
6
Refining the clinical diagnosis of Parkinson's disease.帕金森病的临床诊断细化。
Parkinsonism Relat Disord. 2024 May;122:106041. doi: 10.1016/j.parkreldis.2024.106041. Epub 2024 Feb 10.
7
Analysis of α-syn and interaction in mediating neuronal death in model of Parkinson's disease.α-突触核蛋白及相互作用在帕金森病模型中介导神经元死亡的分析
Front Cell Neurosci. 2024 Jan 4;17:1295805. doi: 10.3389/fncel.2023.1295805. eCollection 2023.
8
History of Parkinson's Disease-Associated Gene, : Research over a Quarter Century in Quest of Finding the Physiological Substrate.帕金森病相关基因的历史:二十五年来寻找生理底物的研究。
Int J Mol Sci. 2023 Nov 24;24(23):16734. doi: 10.3390/ijms242316734.
9
Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson's Disease.源自携带与LRRK2和SNCA相关基因形式帕金森病患者的多巴胺能神经元中的线粒体功能障碍
Curr Issues Mol Biol. 2023 Oct 17;45(10):8395-8411. doi: 10.3390/cimb45100529.
10
A new metabolic model of and the integrative analysis of Parkinson's disease.帕金森病的新代谢模型与综合分析。
Life Sci Alliance. 2023 May 26;6(8). doi: 10.26508/lsa.202201695. Print 2023 Aug.

本文引用的文献

1
Genetic Identification in Early Onset Parkinsonism among Norwegian Patients.挪威早发性帕金森病患者的基因鉴定
Mov Disord Clin Pract. 2017 May 23;4(4):499-508. doi: 10.1002/mdc3.12501. eCollection 2017 Jul-Aug.
2
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.
3
A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.一个携带新型PARK2突变的秘鲁家庭:临床和病理特征
Parkinsonism Relat Disord. 2015 May;21(5):444-8. doi: 10.1016/j.parkreldis.2015.01.005. Epub 2015 Jan 15.
4
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.是时候重新定义帕金森病了?帕金森病定义MDS特别工作组的介绍性声明
Mov Disord. 2014 Apr;29(4):454-62. doi: 10.1002/mds.25844. Epub 2014 Mar 11.
5
Parkin disease: a clinicopathologic entity?帕金森病:一种临床病理实体?
JAMA Neurol. 2013 May;70(5):571-9. doi: 10.1001/jamaneurol.2013.172.
6
Lewy body pathology in a patient with a homozygous parkin deletion.路易体病理改变见于一名纯合子 parkin 缺失患者。
Mov Disord. 2013 Mar;28(3):388-91. doi: 10.1002/mds.25346. Epub 2013 Feb 11.
7
Neuropathological findings in benign tremulous parkinsonism.良性震颤性帕金森病的神经病理学发现。
Mov Disord. 2013 Feb;28(2):145-52. doi: 10.1002/mds.25220. Epub 2012 Dec 12.
8
Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2).一名携带帕金基因(PARK2)杂合(R275W)突变的患者出现路易体病理改变及典型帕金森病。
Acta Neuropathol. 2012 Jun;123(6):901-3. doi: 10.1007/s00401-012-0991-7. Epub 2012 May 4.
9
The neuropathology of genetic Parkinson's disease.遗传帕金森病的神经病理学。
Mov Disord. 2012 Jun;27(7):831-42. doi: 10.1002/mds.24962. Epub 2012 Mar 26.
10
Parkinson-related genetics in patients treated with deep brain stimulation.接受深部脑刺激治疗的帕金森病相关遗传学。
Acta Neurol Scand. 2011 Mar;123(3):201-6. doi: 10.1111/j.1600-0404.2010.01387.x.

一例因纯合外显子缺失导致无路易体病理改变的帕金森病病例

A Case of Parkinson's Disease with No Lewy Body Pathology due to a Homozygous Exon Deletion in .

作者信息

Johansen Krisztina Kunszt, Torp Sverre Helge, Farrer Matthew J, Gustavsson Emil K, Aasly Jan O

机构信息

Department of Neurology, St. Olavs University Hospital, Trondheim, Norway.

Department of Pathology, St. Olavs University Hospital, Trondheim, Norway.

出版信息

Case Rep Neurol Med. 2018 Jun 28;2018:6838965. doi: 10.1155/2018/6838965. eCollection 2018.

DOI:10.1155/2018/6838965
PMID:30050705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6046180/
Abstract

Parkinson's disease (PD) is a clinical diagnosis based on the presence of cardinal motor signs, good response to levodopa, and no other explanations of the syndrome. Earlier diagnostic criteria required autopsy for a definite diagnosis based on neuronal loss in the substantia nigra pars compacta (SNpc) and the presence of Lewy bodies and neurites. Here, we present a patient who developed parkinsonism around the age of 20, with an excellent response to levodopa who, at age 65, received bilateral STN deep brain stimulation (DBS). The patient died at age 79. The autopsy showed severe neuronal loss in the SN without any Lewy bodies in the brainstem or in the hemispheres. Genetic screening revealed a homozygous deletion of exon 3-4 in the gene. In this case report we discuss earlier described pathological findings in cases without Lewy body pathology, the current diagnostic criteria for PD, and their clinical relevance.

摘要

帕金森病(PD)是一种基于主要运动体征的存在、对左旋多巴的良好反应以及该综合征无其他解释的临床诊断。早期的诊断标准需要尸检,以基于黑质致密部(SNpc)的神经元丢失以及路易小体和神经突的存在来明确诊断。在此,我们介绍一位在20岁左右出现帕金森综合征、对左旋多巴反应良好的患者,该患者在65岁时接受了双侧丘脑底核深部脑刺激(DBS)。患者于79岁去世。尸检显示黑质有严重的神经元丢失,脑干或半球中无任何路易小体。基因筛查显示该基因外显子3 - 4纯合缺失。在本病例报告中,我们讨论了早期描述的无路易小体病理的病例中的病理发现、当前PD的诊断标准及其临床相关性。